Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus.

× No keyword cloud information.

13 in total

Review 1. Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.

Authors: Antonie J H H M van Oostrom; Jeroen van Wijk; Manuel Castro Cabezas
Journal: Drugs Date: 2004 Impact factor: 9.546

2. Central effects of humanin on hepatic triglyceride secretion.

Authors: Zhenwei Gong; Kai Su; Lingguang Cui; Emir Tas; Ting Zhang; H Henry Dong; Shoshana Yakar; Radhika H Muzumdar
Journal: Am J Physiol Endocrinol Metab Date: 2015-06-09 Impact factor: 4.310

3. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease.

Authors: Christiane Reitz; Ming-Xin Tang; Nicole Schupf; Jennifer J Manly; Richard Mayeux; José A Luchsinger
Journal: Arch Neurol Date: 2010-12

4. Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids.

Authors: Mirjana Pavlic; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal: Diabetes Date: 2009-12-22 Impact factor: 9.461

5. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.

Authors: Hélène Duez; Benoît Lamarche; René Valéro; Mirjana Pavlic; Spencer Proctor; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal: Circulation Date: 2008-04-28 Impact factor: 29.690

6. Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.

Authors: You-Guo Niu; Rhys D Evans
Journal: J Physiol Date: 2009-05-11 Impact factor: 5.182

Review 7. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.

Authors: Nicola Ferri; Massimiliano Ruscica
Journal: Endocrine Date: 2016-04-01 Impact factor: 3.633

Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus.